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Georgia State University, Atlanta, GeorgiaABSTRACT Virus capsid assembly has been widely studied as a biophysical system, both for its biological and medical
significance and as an important model for complex self-assembly processes. No current technology can monitor assembly
in detail and what information we have on assembly kinetics comes exclusively from in vitro studies. There are many differences
between the intracellular environment and that of an in vitro assembly assay, however, that might be expected to alter assembly
pathways. Here, we explore one specific feature characteristic of the intracellular environment and known to have large effects
on macromolecular assembly processes: molecular crowding. We combine prior particle simulation methods for estimating
crowding effects with coarse-grained stochastic models of capsid assembly, using the crowding models to adjust kinetics of
capsid simulations to examine possible effects of crowding on assembly pathways. Simulations suggest a striking difference
depending on whether or not a system uses nucleation-limited assembly, with crowding tending to promote off-pathway growth
in a nonnucleation-limited model but often enhancing assembly efficiency at high crowding levels even while impeding it at lower
crowding levels in a nucleation-limited model. These models may help us understand how complicated assembly systems may
have evolved to function with high efficiency and fidelity in the densely crowded environment of the cell.INTRODUCTIONVirus capsid assembly has proven to be a powerful model
system for understanding highly complex macromolecular
assembly in general. Nonetheless, many features of the
capsid assembly process, such as detailed binding kinetics
and pathways, remain inaccessible to direct experimental
observation. Given the limited sources of experimental
data, theory and computational simulation methods have
played essential roles in developing detailed functional
models of capsid assembly. Simulation approaches have
proven very effective, for example, at exploring ranges of
possible parameters, identifying those that lead to produc-
tive assembly, and examining the pathways they imply
(1–18). The majority of these simulation approaches can
roughly be classified into either ordinary differential equa-
tion models (1–6), molecular dynamics-like particle models
(7–11) or some variant such as Langevin dynamics (12), or
continuum mechanical models (13,14). This work has, how-
ever, been largely restricted to working with either highly
simplified models with small numbers of parameters
(1–11) or to generic models of capsid assembly in the ab-
stract through which one can explore ranges of possible be-
haviors (13–15). Although models of virus capsid assembly
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0006-3495/14/01/0310/11 $2.00til recently they provided no way to create detailed quanti-
tative models of the kinetics of subunit addition for real
viruses.
In prior work, we developed an approach to address the
problem of learning detailed quantitative models of capsid
assembly kinetics for specific viruses by combining fast
discrete event stochastic simulations of capsid assembly
from generic rule models (19–21) with numerical optimiza-
tion algorithms to fit specific rate constants to experimental
light scattering data (22,23). By tuning parameters to opti-
mize fit of simulated and true light scattering data, this
work made it possible for the first time, to our knowledge,
to learn detailed kinetic models tuned to describe assembly
of specific virus capsids. Applying the method to three
icosahedral viruses—cowpea chlorotic mottle virus
(CCMV), human papillomavirus (HPV), and hepatitis B
virus (HBV)—yielded a set of kinetic pathway models
revealing some common features between systems but
also a surprising diversity of behaviors across the systems.
Learning detailed kinetic models to fit in vitro assembly
data is, however, only one step toward understanding the
natural assembly mechanisms of these or other viruses.
Even a perfectly faithful model of assembly in vitro may
yield limited insight into the natural assembly of the virus
because the in vitro assembly environment itself is quite
different from the environment of a living cell in which a
virus would normally assemble. In principle, computational
methods provide a way to bridge this gap as well, by allow-
ing us to learn interaction parameters of assembly proteins
from the in vitro system then observe how their behavior
changes when transferred to a more faithful computationalhttp://dx.doi.org/10.1016/j.bpj.2013.11.022
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the in vivo intracellular environment is not a simple task,
though, as it differs from the test tube in numerous ways,
many still imperfectly understood. Furthermore, we have
no clear understanding of which of these differences are
actually relevant to assembly kinetics and pathways. For
example, the presence of nucleic acid inside the viral capsid
at the time of assembly can make a large difference in the
thermodynamics of the assembly environment, beyond the
potential direct interactions that may also aid in the assem-
bly process (24–26). The presence of chaperone proteins or
other intracellular machinery can also play a large role in
either promoting or inhibiting the ability of a virus to
form (27,28). The extreme complexity of the true system
and the uncertainty regarding which factors actually affect
assembly pathways suggests the prudence of a bottom-up
approach: studying individual factors of interest and deter-
mining whether they are likely to, singly or in combination,
substantially alter assembly mechanisms.
In this work, we take one step toward answering the ques-
tion of how capsid assembly pathways may differ in vitro
versus in vivo by focusing on a single factor, macromolec-
ular crowding, that sharply distinguishes intracellular from
typical in vitro systems and that is well known to influence
kinetics and thermodynamics of numerous macromolecular
assembly processes (29–32). Predicting the effects of
nonspecific crowding on any particular system is extremely
difficult, because crowding can both inhibit growth, by
slowing diffusion and impeding binding, or promote growth,
by providing an entropic benefit to coalescing into more
compact assembled forms due to excluded volume effects.
There is clear evidence from experiments (33,34) and
computational modeling (15,36,37) for an important role
for crowding in capsid assembly, although the effects of
crowding on complex pathway selection is not characterized
in sufficient detail to explore how assembly pathways of any
particular virus may be affected by intracellular levels of
crowding. Different computational approaches have been
taken to address the effects of crowding with some groups
favoring highly detailed crowding models of ensembles of
cellular crowders to avoid omitting possibly relevant factors
(36,37), whereas others favor incorporating the minimal
detail necessary to yield observed crowding behavior and
argue that simple models can accurately mimic effects of
far more complicated ensembles expected in nature (38).
Although the latter work does not tell us the precise param-
eters a simple uniform-crowder model should have to accu-
rately mimic a cell-like ensemble of distinct crowders, it
does suggest that scanning a range of possible total crowd-
ing levels in a simple uniform model can stand in well for a
much higher dimensional search of possible combinations
of crowder sizes and concentrations that might be present
in any actual system. Because of the size and complexity
of the model systems we study, we have favored the mini-
malist approach of starting from a simple model and incor-porating only complexity shown to be most relevant to
quantifying the effect of macromolecular crowding on
assembly reactions. To this end, we combine two separate
prior modeling approaches—one for simulating capsid
assembly and one for simulating the effects of macromolec-
ular crowding on simple assembly reactions—to explore
ranges of possible crowding effects on model capsid assem-
bly systems. To achieve the high efficiency needed to model
large numbers of trajectories for systems with often very
slow rate-limiting nucleation reactions, we rely on our prior
stochastic simulation models of capsid assembly (19–21),
trained to fit light scattering data on real in vitro capsid
assembly systems (22,23). To model crowding without
compromising runtime, we extend an approach using test
reactions run in a comparatively slow space-aware diffusion
model (39) to train regression models one can use to esti-
mate crowding effects on kinetics of a wide range of param-
eter values (40). To deal with uncertainty in the total
crowding level likely to be encountered by any real viral
system, we apply this model across a broad range of total
crowding levels, from 0% to 45% total excluded volume.
The result is a dual-scale simulation that offers the effi-
ciency of our prior rule-based models, needed for detailed
pathway analysis, combined with physical representations
of a simple particle model of macromolecular crowding.
We use these tools to project possible effects of increased
crowding on three virus systems analyzed in our prior
work: CCMV, HPV, and HBV. The remainder of this work
describes our computational approach in greater detail,
reports apparent effects of increasing levels of computation-
ally simulated crowding on each system, and uses these
results to draw some conclusions about how crowding
may influence these specific viruses or viral assembly
generically.MATERIALS AND METHODS
Capsid simulation method
We have previously developed a rules-based discrete event stochastic simu-
lator called Discrete Event Simulator of Self-Assembly (DESSA) (21) to
model the process of capsid assembly from individual subunit building
blocks through individual association and dissociation events into
completed capsids. Simulated assembly is governed by simple biochemical
rule sets specifying the geometries of the subunits, three-dimensional posi-
tioning of binding sites, and the specificities and on- and off-rates of bind-
ing events between binding sites. DESSA samples among all possible bond
formation (association) and breaking (dissociation) events at each step in
the simulation using a variant of the stochastic simulation algorithm
(41,42). More details of the DESSA simulator and its application here
are provided in the Supporting Material under Discrete Event Simulation
of Capsid Assembly. In the viral systems we study, the individual subunits
can represent either individual coat proteins or small stable oligomers of
coat proteins. In the case of HPV, the subunit corresponds to a pentamer
of HPV capsid proteins, which experimental evidence has shown to be
the basic unit of assembly (43,44). For CCMV and HBV, we use dimers
of coat proteins as the individual subunits, as the experimental data also
involved in vitro assembly from coat dimers (45–48). We assumed kineticBiophysical Journal 106(1) 310–320
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these viruses using a numerical optimization scheme to fit parameters to
minimize the root mean-square deviation between in vitro experimental
static light scattering data and light scattering curves generated based
upon our DESSA simulation output (23). This parameter estimation method
is described in more detail in the Supporting Material under Parameter Esti-
mation from in vitro Data.Modeling the crowding effect
To simulate potential effects of crowding on capsid assembly, we use a
strategy we previously developed to quickly estimate corrections to equilib-
rium constants to account for crowding in complex assembly models. This
method was intended to address the problem that simplified stochastic
models used in our large-scale assembly simulations cannot model crowd-
ing effects, although the more realistic explicit particle models that can
represent crowding are too slow to handle the large numbers of particles
and simulation trajectories required for our studies. The method first uses
off-lattice particle models implemented with Green’s function reaction
dynamics (49) to test effects of varying levels of a homogeneous nonspe-
cific crowding agent on a generic homodimerization test system for a range
of model parameters (39). It then trains a regression model to predict Keq
values as functions of the parameters. Additional test simulations are
used to derive corrections to diffusion rate and thus corrections to forward
rates of binding (kþ) under a model of diffusion-limited binding for each
crowding level. The combination of the regression model ofKeq and the cor-
rections to kþ provide a fast surrogate to allow us to adjust kinetic rates at
each binding site and crowding level to provide a model of altered binding
kinetics in the presence of crowding. These corrected rates are then fed into
the DESSA simulator to provide self-assembly simulations intended to
reflect altered kinetics due to molecular crowding. The overall method is
discussed in more detail in the Supporting Material under Molecular
Crowding Simulation and Regression Model of Crowding Effects.Simulation experiments
For each virus, we produced crowding-corrected parameter files for crowd-
ing agent levels from 0% to 45% in increments of 5%, with rate parameters
determined relative to the best-fit in vitro parameters for all three viruses,
presumed to represent 0% nonspecific molecular crowding. We then ran
100 simulation trajectories for each virus at each crowding level, to allow
for adequate sampling given the stochasticity of our simulator. For each
simulation, we followed the same protocols as our previous work (23).
For HBV and CCMV, each simulation was begun using enough initial
free subunits to generate five complete capsids per simulation: 450 subunits
for CCMVand 600 subunits for HBV. For HPV, to ensure in the 0% crowd-
ing agent case a greater likelihood of producing at least one completedTABLE 1 Crowding-corrections for equilibrium constants, on-rates
simulator and regression model
Crowding level 0% 5% 10% 1
HPV Keqð1024mol1m2Þ 1 1.26 1.39 1
kþ (10
16 mol-1m3s1) 1 .683 .474 .
k- (10
8 ms1) 1 .543 .341 .
CCMV Keqð1024mol1m2Þ 1 1.32 1.45 1
kþ (10
16 mol-1m3s1) 1 .683 .474 .
k- (10
8 ms1) 1 .517 .326 .
HBV Keqð1024mol1m2Þ 1 1.34 1.47 1
kþ (10
16 mol-1m3s1) 1 .683 .474 .
k- (10
8 ms1) 1 .508 .322 .
The corrections calculated here are applied to the best-fit in vitro parameters of o
ditions.
Biophysical Journal 106(1) 310–320capsid, each simulation was begun using enough subunits to generate 10
complete capsids per simulation: 720 subunits total. Each simulation
ends when all capsids have been formed, there are no events left in the
simulation queue, or a predetermined simulation time limit empirically
determined to allow simulations to go to pseudoequilibrium is reached.
For these simulations, the time limit for CCMV and HBV was set to
1000 s, whereas the time limit for HPV was set to 150,000 s because of
the far greater time required to assemble an HPV capsid in vitro and
in silico.
We then analyzed the trajectories to derive summaries of assembly
pathways in the form of tables of frequencies of possible binding inter-
actions and time series of mass fractions of different sizes of species versus
time for each trajectory. Such indirect measures of pathways are necessary
because the true number of pathways will generally be exponentially large
in the size of the structure to be assembled. To construct the binding
frequency tables, we count all association events that occur across all
repetitions of each simulation input and produce a matrix with one row
or column for each subunit contained in a completed capsid. We place in
position (i, j) the count of all bond-forming events involving an assembly
of j subunits producing an assembly of i subunits. We then scale each
row by the total number of association events involving the production of
an assembly of i subunits, so that each position in the matrix contains a fre-
quency between 0 and 1. To construct mass fraction plots, we record after
each 100 simulation events the quantity of each assembly size (from mono-
mer to complete capsid) currently present in the simulator. We then scale
each of these assembly size counts by the number of subunits present in
the assembly (e.g., a pentamer is scaled by five as the mass of a pentamer
in each simulation would be five times that of a monomer). We finally
normalize each value such that it represents the frequency, between 0 and
1, instead of the total count of subunits in each assembly size. We plot
this value versus simulation time for each potential assembly size. We
further develop aggregate measures of assembly kinetics based on the
average time required over a set of trajectories to reach 50% or 67%
completion of potential capsids.RESULTS AND DISCUSSION
Estimating crowding corrections for capsid coat
binding reactions
Table 1 shows relative crowding corrections for equilibrium
and rate constants for each virus at crowding levels from 0%
to 45%. By crowding level, we refer throughout the results
to the percentage of nonspecific crowding (0% and 45%)
rather than the total crowding to avoid confusion due to
the slight differences in volume contributed by the viral, and off-rates for HPV, CCMV, and HBV generated by the GFRD
5% 20% 25% 30% 35% 40% 45%
.54 1.87 2.54 3.88 6.46 11.9 26.8
340 .252 .193 .147 .106 .069 .041
221 .135 .076 .038 .016 .006 .002
.65 1.96 2.68 4.04 6.60 12.0 27.1
340 .252 .193 .147 .106 .069 .041
206 .128 .072 .036 .016 .006 .002
.69 1.98 2.71 4.06 6.63 12.0 27.1
340 .252 .193 .147 .106 .069 .041
201 .127 .071 .036 .016 .006 .002
ur capsid assembly simulator to reflect increasingly crowded assembly con-
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will be between one and three-hundredths of a percent
higher than these stated crowding levels, depending upon
the virus. The table shows a general trend toward increased
Keq with an increasing crowding level, concurrent with
simultaneous decreases in both kþ and k- with increasing
crowding. This effect is similar to that observed in prior
uses of these crowding models (39,40). The corrections in
Table 1 provide scaling factors needed to adjust our previous
in vitro best-fit kinetic rates (23) to more accurately model
increasing crowding levels for each virus. Table S1 in the
Supporting Material lists the corrected kinetic on- and off-
rates for each virus binding reaction at each crowding level.Effects of crowding on bulk kinetics of simulated
assembly
We next ran replicates of assembly simulations for each of
the three viruses and 10 crowding levels. Fig. 1 shows simu-
lated light scattering curves for CCMV, HBV, and HPV ateach crowding concentration, averaged over 100 trajectories
per crowding level.
Fig. 1 a shows results for CCMV. At low crowding levels,
the figure shows a pattern of decreasing speed and yield
of assembly, with the assembly rate reaching a minimum
at 25% crowding. The effect reverses at higher crowding
levels, with the assembly rate at 35% crowding approaching
that of the uncrowded system, and with 40% and 45%
crowding yielding faster assembly at intermediate time
points of the simulation. All trajectories go to equivalent
levels of completion eventually, although with varying
kinetics.
Fig. 1 b shows curves for HBV, which show qualitatively
similar behavior to those for CCMV. HBV also shows a
pattern of decreasing speed and quantity of assembly at
low crowding levels, again reaching a minimum at 25%
crowding, but increased assembly with respect to both speed
and yield as crowding levels continue to increase. Crowding
levels above 30% begin to approach the assembly rate of the
0% crowding state. 45% crowding yields higher assemblyFIGURE 1 Simulated light scattering curves for
CCMV (a), HBV (b), and HPV (c). Each curve
represents an average simulated light scattering
over 100 simulation trajectories. Curves are shown
for levels of nonspecific crowding agents from 0%
to 45% of simulation solution volume in increments
of 5%.
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FIGURE 2 Average times required to reach 50% (a) and 67% (b)
completed capsids for HPV, HBV, and CCMVmodels. All graphs are scaled
to yield a starting time of 1 at 0% crowding. Subsequent crowding levels
show the multiple of that initial time required to reach a given level of
completion at a given crowding level. The inset in each figure represents
a graph of just HBV and CCMV to highlight variations that are obscured
by the large change in HPV completion times as a function of crowding
level.
314 Smith et al.rates than 0% crowding levels in the later stages of assem-
bly. HBV yields a higher apparent variance in the final yield
of completed capsids than does CCMV. With HBV, assem-
bly yield initially drops along with assembly rate as crowd-
ing is introduced, with yields at 10–35% crowding well
below those of the uncrowded case. Yield approaches that
of the uncrowded system by 40% crowding and surpasses
it at 45% crowding.
Fig. 1 c shows curves for HPV, which show strikingly
different behavior than the CCMV or HBV simulations.
HPV shows a monotonic decrease in both rate and yield
of assembly with increasing crowding rates. The curves
also show a much lower variance than did the HBV or
CCMV curves, with the effects of increasing crowding
clearly distinguishable from the noise in the individual aver-
aged simulated light scattering curves.
We next chose to look in greater detail at the kinetic
effects of crowding on the different viruses’ assemblies by
comparing the average time required for each virus to reach
50% completion and 67% completion of the capsids in
simulation. These measures are used to bypass a problem
of mass averaging across assembly sizes in light scattering
curves, namely that it tends to conflate productive assembly
leading to complete capsids with unproductive off-pathway
assembly leading to kinetically trapped intermediates. Fig. 2
plots these times to partial completion for all crowding
levels examined for the three viruses. Fig. 2, a and b,
show a dramatic difference again between how the HPV
model reacts to increased crowding compared to the
CCMV and HBV models, with the CCMV and HBV times
largely stable across crowding levels but the HPV times
increasing greatly with higher crowding. Because the large
change in HPV times makes it difficult to appreciate varia-
tions in CCMV or HBV times on a common scale, we add
insets to the figures showing results solely for CCMV and
HBV. The insets show an increase in time required for
both viruses at low crowding levels, peaking between 20%
and 25% crowding. Both viruses show about a 125%
increase in time to 50% completion and a 75% increase
for HBV in time and a 150% increase for CCMV in time
to 67% completion. At higher crowding levels, CCMV
shows a reduction in relative time to a local minimum at
35% crowding for both the 50% (a) and 67% (b) completion
graphs. The average times then slightly increase again at the
highest crowding levels. The highest crowding levels for
CCMV are slower to reach 50% and 67% completion than
the 0% level, although the higher levels eventually yield
faster kinetics to reach 80% completion. For HBV, there is
no local minimum at 35% as the relative time decreases at
all crowding levels above 20%. 45% crowding approaches
the 0% crowding case in 50% completion time (Fig. 2 a)
and there is a reduction in relative time for the highest
crowding level for the 67% completion time (Fig. 2 b).
The figure implies that crowding acts earlier in HBV than
CCMV assembly to accelerate the process.Biophysical Journal 106(1) 310–320Crowding effects on individual assembly
trajectories
We next examined individual assembly trajectories to gain
insight into the mechanisms by which crowding enhances
bulk assembly of the HBV and CCMV models and
suppresses bulk assembly of the HPV model. To this end,
we produced plots of mass fractions of each assembly
size over time for each virus at each crowding level.
Although space would not allow us to show such figures
for all simulation trajectories, we provide an illustrative
sample in Fig. 3. Fig. 3, a, d, and g, show mass fraction
plots for the three viruses with negligible crowding. The
short peaks present in the HBV and CCMV plots (Fig. 3,
a and d), correspond to nucleation events followed by
the rapid production of finished capsids, a feature absent
from the HPV plot (Fig. 3 g). Both HBV and CCMV also
maintain pools of trimers-of-dimers, which we previously
found in uncrowded simulations to be an important parti-
cipant in the assembly pathways for these viruses (23). No
large pools of assemblies are consistently present for either
HBV or CCMV, aside from monomers, complete capsids,
FIGURE 3 Mass fraction plots for CCMVat crowding levels of 0% (a), 20% (b), and 40% (c), HBVat crowding levels 0% (d), 20% (e), and 40% (f), and
HPV at crowding levels of 0% (g), 20% (h), and 40% (i). Each plot shows a mass fraction for each size of intermediate versus time. The large number of
intermediates makes it impractical to provide a full color key and necessitates repeating colors; however, the most frequently observed intermediates are
colored as follows: Monomers are blue, trimers are red, and pentamers are purple. The plateauing yellow line for CCMV and blue line for HBV represent
completed capsids.
Crowding Models of Virus Capsid Assembly 315and this trimer-of-dimers intermediate. HPV, by contrast,
shows a growing pool of partially assembled structures of
varying sizes that form and then persist throughout the simu-
lation. This latter pattern is indicative of kinetic trapping, in
which many partial capsids form simultaneously and
deplete free monomers to such a degree, that none can
assemble to completion. This kinetic trapping has been
previously observed in many capsid assembly models
(5,6,21,23,50–53).
In Fig. 3, b, e, and h, we examine the changes in individ-
ual simulation trajectories induced by moderate (20%)
crowding levels. Fig. 3 b, a trajectory of CCMV with 20%
crowding, shows a qualitatively similar picture to that of
CCMV without crowding: a growth process with clearly
defined nucleation events each touching off growth of a
single capsid. Quantitatively, however, the process is slowed
in both the nucleation and growth phases. Nucleation events
are more widely spaced and the peaks corresponding to
growth after nucleation are noticeably widened relative to
the uncrowded case. The introduction of crowding also
seems to produce a visible pool of 10-mers of dimers only
evident for brief time periods in the uncrowded case; subse-
quent analysis showed this pool to be present for the major-ity of simulation runs at crowding levels between 10% and
25%. For levels lower than 10% and above 25%, 10-mers of
dimers are still produced, although they are then added to
larger assemblies at fast enough rates that no consistent
pools are formed, except toward the end of simulation
runs when assembly slows down due to fewer unbound
capsid proteins available to take part in assembly reactions.
Fig. 3 e shows that, for HBV, 20% crowding yields similar
appearances for individual trajectories save for an increase
in time to assemble and a lower likelihood of completing
as many capsids by the end of the simulation time. There
is no pool of 10 mers-of-dimers at 20% crowding for
HBV, unlike CCMV. Fig. 3 h shows a highly distinct effect
of simulated crowding on the HPV model. Kinetic trapping
is visible both with and without crowding, with simulated
capsomers largely absorbed into partially formed structures
rather than complete capsids at both crowding levels. There
is, however, a noticeable shift in the crowding simulations
toward smaller partial intermediates.
Fig. 3, c, f, and i, show the effects on assembly trajectories
as crowding is increased to 40%. CCMV shows a greatly
increased assembly rate for the majority of potential cap-
sids, to the point that the process no longer appearsBiophysical Journal 106(1) 310–320
316 Smith et al.nucleation limited. Although the nucleation-like peaks are
still present, they now overlap, indicating multiple capsids
in their elongation phases simultaneously. The second, third,
and fourth capsids assemble nearly simultaneously. The
fifth, however, takes far longer than the original four to
assemble, as the effects of reduced free subunits greatly
slow bond formation. We note that this slow growth yields
an opportunity to observe step-by-step addition of each sub-
assembly to the growing capsid. A combination of single
dimer, dimer-of-dimers, and trimer-of-dimers additions all
occur during the assembly process.
A similar pattern can be seen with regard to HBV in Fig. 3
f. At 40% crowding, assembly is greatly accelerated relative
to lower crowding levels. Peaks corresponding to nucleation
and subsequent growth of individual capsids remain clearly
defined, unlike in the CCMV case, but nonetheless begin to
run together. One feature of note in the 40% crowding case
is the presence of a small pool of pentamers-of-dimers early
in the assembly process before the rapid nucleation and
assembly of the first four capsids. In each case, only four
of the five potential capsids are produced. It is also notable
that after the last capsid is formed, there are no assemblies
present other than persistent populations of completed
capsids, single dimers, dimers-of-dimers, and trimers-of-
dimers, and the transient appearance of occasional
tetramers-of-dimers. There is no construction of pentam-
ers-of-dimers, which are often seen forming shortly before
a nucleation step in HBV trajectories.
For HPVassembly, the sample trajectory for 40% crowd-
ing in Fig. 3 i shows a qualitatively similar picture to that for
20% crowding in Fig. 3 h. The system is unable to produce
completed capsids, instead yielding a spectrum of partially
built, kinetically trapped forms. There is a further noticeable
shift toward smaller trapped species relative to the un-
crowded case. Meaningful differences between 20% and
40% crowding are difficult to discern from single trajec-
tories, although Fig. 1 c implies that the shift toward smaller
trapped species continues as crowding levels increase.Measuring average pathway usage across
trajectories
Another way to examine the changes seen in the assembly
pathways for these viruses is to measure frequencies with
which individual bonds are observed, averaged over many
trajectories. Fig. 4 shows a visualization of these bond
frequency tables, showing relative frequencies with which
different assembly sizes are used as reactants in producing
any given larger assembly size (e.g., the frequency with
which a dimer is a reactant to a reaction producing a
pentamer). Fig. 4, a and b, show the progression in bond
frequency tables for CCMV at negligible and 40% crowd-
ing, in each case averaged over 100 simulation trajectories.
Both crowding levels yield similar bond usage patterns, with
essentially the same combinations of reaction steps. In eachBiophysical Journal 106(1) 310–320case, assembly proceeds by addition of either subunit mono-
mers (coat dimers), subunit trimers (coat trimers-of-dimers),
or, in some early steps, subunit pentamers (coat pentamers-
of-dimers). Most steps favor monomer addition with a low
frequency of trimer addition, aside from a few conserved
steps with high trimer frequency early in assembly. How-
ever, two changes are noted in the 40% crowding case. First,
there is an overall trend toward an increased use of single
dimers versus trimers-of-dimer or pentamers-of-dimer at
40% crowding. Second, there is an increased frequency of
reactions involving larger intermediates in the 40% crowd-
ing case, potentially out of necessity as binding reactions
become less kinetically favorable.
Fig. 4, c and d, show comparable plots for the HBV
model. For HBV, as for CCMV, we see a pathway character-
ized predominantly by monomer addition, with a lesser rate
of trimer addition. There are, however, a few conserved
steps at which trimer addition is used preferentially. HBV
shows only rare pentamer additions at a few early steps.
As with CCMV, pathways are qualitatively similar across
crowding levels, but again a slight trend occurs toward
increased preference for assembly by single dimers versus
other small oligomers and more frequent appearances of in-
teractions between larger assemblies at 40% crowding.
Fig. 4, e and f, show a very different portrait again for
HPV. As in our previous work (19,20), we find that HPV
assembly is driven almost entirely by single capsomer addi-
tions. However, as crowding levels increase, the frequency
of other binding events occurring also begins to increase.
By the 40% crowding level every binding combination of
sizes is observed at least infrequently among the lower
assembly sizes. Thus, although crowding reduces the
frequency of usage of minor assembly pathways for
CCMV and HBV, it increases their use for HPV. We note
that the final two rows of the HPV bond frequency table
for 40% crowding are all white, showing that no binding
events result in assemblies of>70 capsomers (HPV consists
of 72 capsomers in our model) and thus that the HPV model
was unable to assemble any complete capsids at the 40%
crowding level.CONCLUSION
This work is intended to take one step toward transitioning
capsid assembly simulation away from models of in vitro
environments toward more realistic representations of
in vivo capsid assembly, with a specific focus on modeling
the possible effects of macromolecular crowding on assem-
bly. By using a previously developed approach for inferring
the influence of crowding on association and dissociation
rates of assembly reactions, we adjusted models of capsid
assembly learned from in vitro data to better reflect how
the coat subunits studied might behave in a crowded envi-
ronment such as a living cell. Although the exact effects
of crowding are notoriously hard to predict with accuracy,
FIGURE 4 Binding frequency tables for CCMVat crowding levels of 0% (a) and 40% (b), HBV at crowding levels of 0% (c), and 40% (d), and HPV at
crowding levels of 0% (e) and 40% (f). Each pixel shows the frequency with which a particular reactant size (x axis) is used to produce a particular product
size (y axis). A scale bar relating shading to frequency appears on the right.
Crowding Models of Virus Capsid Assembly 317we can infer general trends by scanning across a range of
possible simulated crowding levels. The resulting computa-
tional models made it possible to analyze detailed simulated
assembly trajectories for three different icosahedral vi-
ruses—CCMV, HBV, and HPV—under levels of crowding
between 0% and 45%, a range that should span the range
from typical in vitro to plausible in vivo crowding levels.The study revealed an important distinction between
the effects of crowding on nucleation-limited capsid assem-
bly and nonnucleation-limited capsid assembly. In partic-
ular, growth in the absence of a defined nucleation step
generally was impeded by crowding, as the net acceleration
of coat-coat binding led primarily to increased kinetic
trapping and thus to a loss of productive assembly.Biophysical Journal 106(1) 310–320
318 Smith et al.Nucleation-limited growth, previously known to provide
protection against kinetic trapping (19,21), appeared to
provide a similar buffer against kinetic trapping that would
otherwise be induced by crowding, allowing crowding to
accelerate rather than inhibit productive assembly. We can
speculate that the reason this effect can occur in our detailed
assembly models is that nucleation is not a single step;
crowding-induced changes in both forward and reverse rates
of intermediate steps leading to nucleation can simul-
taneously slow each individual assembly step and yet
accelerate the overall assembly rate. Furthermore, nucle-
ation-limited assembly buffers against off-pathway growth,
allowing this acceleration without an increase in off-
pathway assembly over at least a broad range of crowding
levels.
This enhancement of assembly through crowding
operates over a limited range of crowding levels as the
buffer effect will eventually break down when nucleation
events occur in too rapid succession, which we begin to
see for CCMV at the highest crowding levels. Nucleation-
limited growth allows crowding to work to promote
effective growth, but a sufficiently strong crowding effect
will itself block nucleation-limited growth. These effects
are evident in a shift of both of the nucleation-limited
capsids toward a single monomer-accretion pathway,
evident in Fig. 4, as well as in the overlapping nucleation/
elongation peaks seen for these viruses in 40% crowding
trajectories in Fig. 3. These results suggest that crowding
is neither inherently a benefit nor a disadvantage to capsids,
but rather a complicated effect variable across biologically
plausible parameter domains. One can conjecture that vi-
ruses would evolve to function effectively in the domains
in which they operate in nature. Understanding these
tradeoffs may be helpful in better designing in vitro
systems for capsids or other complex self-assemblies as
well as in the design of novel self-assembling nanotech-
nology that might take advantage of similar environmental
factors.
A key question for this work is to understand the degree to
which we can trust that results from models, whether
computational or in vitro, accurately reflect what happens
in the cell. Our simulations suggest a mixed answer. Our
results suggest that, at least for nucleation-limited assembly
processes, assembly mechanisms and pathways are well
conserved over a broad range of crowding values likely to
cover both in vitro and in vivo levels of crowding. This
observation would suggest that one can, indeed, use conclu-
sions from the in vitro system to make predictions about
pathways in vivo. This is a question that may have important
practical consequences, such as for strategies for developing
capsid assembly targeted antivirals (54–56). On the other
hand, our models suggest significant quantitative differ-
ences in assembly rate and yield can be induced by crowd-
ing and that one thus cannot make accurate quantitative
predictions about yield of a capsid system withoutBiophysical Journal 106(1) 310–320adequately accounting for crowding in that system. This
observation, too, may have important practical conse-
quences. For example, one might expect that changes in
usage of minor assembly pathways could substantially alter
a virus’s ability to resist an assembly targeted drug.
The work presented here is intended to make one step
forward in understanding how conditions in the cell might
alter pathways for complex self-assemblies such as a viral
capsid, with focus on the specific factor of molecular crowd-
ing, but it still falls far short of a real representation of viral
capsid assembly in vivo. Designing computational models
that better represent the conditions in which viruses nor-
mally assemble is essential to developing biologically accu-
rate and predictive models of virus assembly in vivo.
Furthermore, crowding effects themselves are complex
and difficult to predict. We cannot claim that any particular
parameter choices in our model will accurately measure the
effect of crowding on the specific viral systems examined
here. By exploring a range of values of crowding effects
and the general trends across that range, we can, however,
make general observations likely to prove useful despite
imprecision in predicting crowding effects precisely. None-
theless, improved crowding models or better empirical evi-
dence from which to parameterize them for these specific
systems would be valuable in making more specific and
confident predictions. Furthermore, numerous other factors
interact with growing capsids in the cell, including a diverse
array of binding partners, chaperones, cytoskeletal struc-
tures, nucleic acid to be packaged or encapsidated in the
final capsid product, and likely other actors not yet known
to us. Determining which of these are actually relevant to
modulating assembly pathways and how they act, singly
and in combination, will require extensive work, both exper-
imental and computational.
This work might be advanced in several ways. First, as
both our prior work and the present work shows, the se-
quences of reaction steps needed for nucleation and growth
inferred by our models are more complicated than simple
nucleation-growth models have generally assumed, with
growth proceeding in a complicated cascade of seemingly
idiosyncratic but often clearly conserved patterns of inter-
actions of different specific intermediate species. Better
understanding these specific steps, and how variations in
environment modulate them, remains a challenging but
important problem. A further issue is more precisely and
reliably predicting the specific parameters underlying the
simulations. In part, that is an issue of eliminating uncer-
tainty in the inferences of parameters in vitro, which might
be accomplished by more extensive or richer experimental
data from which to learn and improved algorithms for model
fitting. Simulations must inherently make tradeoffs between
model complexity, computational efficiency, and learnabil-
ity of model parameters. As computing power, algorithms,
and experimental methods for monitoring capsid assembly
improve, it should become possible to move to more
Crowding Models of Virus Capsid Assembly 319detailed and realistic models. Future extensions might
include larger parameter sets accounting for potential allo-
steric interactions between subunits, flexibility in bonding
to allow for misassembly of capsids, more detailed models
of ensembles of molecules contributing to crowding, and
models of other cellular components that might influence
the assembly process. Fulfilling this long-term agenda of
realistic models of assembly in the cell will require not
just computational advances but also developing a better
knowledge of the many other factors that influence virus
capsid assembly in the cell and developing more precise
quantitative models of how these factors influence the as-
sembly process in vivo.SUPPORTING MATERIAL
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